Prosecution Insights
Prosecution Insights
20 pending office actions • 6 art units • 14 examiners • 0 of 20 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (5%) |
| §103 only | 7 (35%) |
| Double-patenting only | 3 (15%) |
| Double-patenting + other | 1 (5%) |
| Multi-statute (no §101) | 7 (35%) |
| No statute on record | 1 (5%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| POLIAKOVA-GEORGAN, EKATERINA | 5 | 64.0% | +17.9% |
| VYAS, KEYUR ANILKUMAR | 3 | 52.1% | +64.0% |
| BEANE, RANDALL L | 1 | 32.8% | +36.6% |
| KRISHNAN, GANAPATHY | 1 | 52.4% | +0.5% |
| SHIN, DANA H | 1 | 27.0% | +27.4% |
| TATGE, LEXUS MARC | 1 | 50.0% | +100.0% |
| MEYERING, SHABANA SHABBEER | 1 | 69.7% | +41.8% |
| KONOPKA, CATHERINE ANNE | 1 | 58.2% | +64.5% |
| CHONG, KIMBERLY | 1 | 72.4% | +12.8% |
| GOLDBERG, JEANINE ANNE | 1 | 45.9% | +40.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17721765 | Compositions for Modulating C9ORF72 Expression | PERSONS, JENNA L | 9d overdue |
| 18262438 | COMPOUNDS AND METHODS FOR REDUCING DUX4 EXPRESSION | KONOPKA, CATHERINE ANNE | 8d overdue |
| 17416108 | MODULATORS OF HSD17B13 EXPRESSION | ANGELL, JON E | 4d overdue |
| 18001848 | COMPOUNDS AND METHODS FOR MODULATING PMP22 | POLIAKOVA-GEORGAN, EKATERINA | 3d overdue |
| 16951449 | Compounds and Methods for Modulation of Transcript Processing | VYAS, KEYUR ANILKUMAR | 2d overdue |
| 18448392 | Selective Antisense Compounds and Uses Thereof | SHIN, DANA H | — |
| 18358591 | COMPOUNDS AND METHODS FOR MODULATING TMPRSS6 EXPRESSION | MEYERING, SHABANA SHABBEER | — |
| 17908135 | COMPOUNDS AND METHODS FOR MODULATING KCNQ2 | CHONG, KIMBERLY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18443619 | COMPOUNDS AND METHODS FOR REDUCING APP EXPRESSION | VYAS, KEYUR ANILKUMAR | 282d overdue |
| 18150395 | ANTISENSE COMPOUNDS | VYAS, KEYUR ANILKUMAR | 247d overdue |
| 18585339 | GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF | BEANE, RANDALL L | 15d overdue |
| 17372173 | MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS | POLIAKOVA-GEORGAN, EKATERINA | 10d overdue |
| 18262438 | COMPOUNDS AND METHODS FOR REDUCING DUX4 EXPRESSION | KONOPKA, CATHERINE ANNE | 8d overdue |
| 18247567 | METHODS FOR REDUCING APOCIII EXPRESSION | POLIAKOVA-GEORGAN, EKATERINA | 4d overdue |
| 18001848 | COMPOUNDS AND METHODS FOR MODULATING PMP22 | POLIAKOVA-GEORGAN, EKATERINA | 3d overdue |
| 16951449 | Compounds and Methods for Modulation of Transcript Processing | VYAS, KEYUR ANILKUMAR | 2d overdue |
| Art Unit | Apps |
|---|---|
| 1637 | 12 |
| 1635 | 4 |
| 1654 | 1 |
| 1693 | 1 |
| 1636 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18585339 | GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF | BEANE, RANDALL L | 1654 | §103Other | Final Rejection | 15d overdue | Pending | Feb 23, 2024 |
| 18443619 | COMPOUNDS AND METHODS FOR REDUCING APP EXPRESSION | VYAS, KEYUR ANILKUMAR | 1637 | §103 | Final Rejection | 282d overdue | Pending | Feb 16, 2024 |
| 18548711 | PURIFICATION METHODS FOR OLIGOMERIC COMPOUNDS | KRISHNAN, GANAPATHY | 1693 | §103 | Non-Final OA | 8d | Pending | Sep 01, 2023 |
| 18457941 | MODULATORS OF PNPLA3 EXPRESSION | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §112DPOther | Non-Final OA | — | Pending | Aug 29, 2023 |
| 18448392 | Selective Antisense Compounds and Uses Thereof | SHIN, DANA H | 1635 | DP | Final Rejection | — | Pending | Aug 11, 2023 |
| 18263194 | COMPOUNDS AND METHODS FOR MODULATING HUNTINGTIN | TATGE, LEXUS MARC | 1637 | §103 | Non-Final OA | 13d | Pending | Jul 27, 2023 |
| 18358591 | COMPOUNDS AND METHODS FOR MODULATING TMPRSS6 EXPRESSION | MEYERING, SHABANA SHABBEER | 1635 | §102§103§112 | Non-Final OA | — | Pending | Jul 25, 2023 |
| 18262438 | COMPOUNDS AND METHODS FOR REDUCING DUX4 EXPRESSION | KONOPKA, CATHERINE ANNE | 1635 | §101§103§112Other | Non-Final OA | 8d overdue | Pending | Jul 21, 2023 |
| 18247567 | METHODS FOR REDUCING APOCIII EXPRESSION | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §103Other | Non-Final OA | 4d overdue | Pending | Mar 31, 2023 |
| 18150395 | ANTISENSE COMPOUNDS | VYAS, KEYUR ANILKUMAR | 1637 | Other | Non-Final OA | 247d overdue | Pending | Jan 05, 2023 |
| 18001848 | COMPOUNDS AND METHODS FOR MODULATING PMP22 | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §102§103 | Non-Final OA | 3d overdue | Pending | Dec 14, 2022 |
| 17908773 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING PREKALLIKREIN-ASSOCIATED CONDITIONS | POLIAKOVA-GEORGAN, EKATERINA | 1637 | DP | Final Rejection | — | Pending | Sep 01, 2022 |
| 17908135 | COMPOUNDS AND METHODS FOR MODULATING KCNQ2 | CHONG, KIMBERLY | 1636 | §102§103§112 | Non-Final OA | — | Pending | Aug 30, 2022 |
| 17812401 | GENE THERAPY AND TARGETED DELIVERY OF CONJUGATED COMPOUNDS | GOLDBERG, JEANINE ANNE | 1682 | §103 | Final Rejection | — | Pending | Jul 13, 2022 |
| 17721765 | Compositions for Modulating C9ORF72 Expression | PERSONS, JENNA L | 1637 | §102§103Other | Final Rejection | 9d overdue | Pending | Apr 15, 2022 |
| 17508516 | COMPOUNDS AND METHODS FOR REDUCING SPDEF EXPRESSION | ZARA, JANE J | 1637 | §102§103§112 | Non-Final OA | — | Pending | Oct 22, 2021 |
| 17372173 | MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §103 | Final Rejection | 10d overdue | Pending | Jul 09, 2021 |
| 17416108 | MODULATORS OF HSD17B13 EXPRESSION | ANGELL, JON E | 1637 | §102§112 | Final Rejection | 4d overdue | Pending | Jun 18, 2021 |
| 17282335 | MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | SULLIVAN, STEPHANIE LAUREN | 1635 | DP | Non-Final OA | — | Pending | Apr 01, 2021 |
| 16951449 | Compounds and Methods for Modulation of Transcript Processing | VYAS, KEYUR ANILKUMAR | 1637 | §102§103§112Other | Final Rejection | 2d overdue | Pending | Nov 18, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial